// June 26, 2023
Complex generics: Are global regulators addressing the needs?
The development of generic versions of innovator medicines is a global public health need.
The development of generic versions of innovator medicines is a global public health need.
The issue of addressing potential nitrosamine impurities in medicines has been the focus at event
Revised on: January 17, 2023
Impurities found in pharmaceuticals are a cause for concern.